Surgical Reversal Of Presbyopia FDA Monitored Clinical Trials

Principal Investigator 

Barrie Soloway, M.D., F.A.C.S.

Enrollment Status

Ongoing

Overview

We are using Refocus (formerly PresbyCorp) Group's Presview implant during these trials, the same implant that Dr. Soloway has successfully used for years on scores of patients treated in the United States during clinical trials and on numerous trips abroad. A complete eye examination at Vista is required to determine your ocular health and to see if you qualify for this study. These trials are sponsored by Refocus Group. Patients selected for this trial will have all medical, surgical and hospital care fees paid for by the sponsor. Next to not needing reading glasses, the best thing is that If you are a candidate for this innovative outpatient surgery, all costs relating to the surgery and its follow-up are paid for by Refocus, the study sponsor.

Inclusion Criteria

Exclusion Criteria

Sponsor   

Refocus

Contact Information

Alliance Eye Care Associates Study Coordinator
160 East 56th Street - 9th Floor, New York, NY 10022
1-888-821-EYES, or vista@ihateglasses.com

 

Home > Current Research > Clinical Trials in Ophthalmology > SURGICAL REVERSAL OF PRESBYOPIA FDA MONITORED CLINICAL TRIALS